Early-Onset Generalized Pustular Psoriasis of Pregnancy Following Hydroxychloroquine Use

다국어 초록 (Multilingual Abstract)

Generalized pustular psoriasis of pregnancy (GPPP), characterized by widespread sterile pustules and erythematous patches with systemic symptoms such as fever, is a rare form of pustular psoriasis. GPPP typically occurs in the third trimester of pregnancy and can be triggered by various factors such as infections, hypocalcemia, and drugs including N- butyl-scopolammonium bromide. We report a rare case of new-onset GPPP in a 33-year- old multigravida female at 17 weeks’ gestation, which occurred earlier than usual, after taking hydroxychloroquine for 3 weeks to treat systemic lupus erythematosus. She stopped her medications and was treated with systemic corticosteroid, but without improvement.
Her medication was changed to systemic cyclosporine; her skin lesions improved, which completely resolved after delivery. This is the first case of GPPP developed following hy- droxychloroquine use for systemic lupus erythematosus, which occurred earlier than usual and completely resolved after delivery. This case demonstrates that hydroxychloroquine can induce GPPP before the third trimester of pregnancy.

참고문헌 (Reference)

1 정기헌 ; 신민경 ; 양윤석 ; 김낙인, "전신 스테로이드제와 단파장 자외선 B로 치료한 임산부의 전신성 농포성 건선 1예" 대한피부과학회 46 (46): 1551-1554, 2008

2 Von Hebra F, "Ueber einzelne während schwangerschaft, des wochenbettes und bei uterinalkrankheiten der frauen zu beobachtende hautkrankheiten" 22 : 1197-1202, 1872

3 Wolf R, "The in vitro effect of hydroxychloroquine on skin morphology in psoriasis" 38 : 154-157, 1999

4 Gravani A, "Synthetic antimalarial drugs and the triggering of psoriasis-do we need disease-specific guidelines for the management of patients with psoriasis at risk of malaria?" 53 : 327-330, 2014

5 Yoshikawa M, "Significance of IL36RN mutation analyses in the management of impetigo herpetiformis : a case report and review of published cases" 48 : 699-702, 2021

6 Trivedi MK, "Pustular psoriasis of pregnancy : current perspectives" 10 : 109-115, 2018

7 Maglie R, "Pustular psoriasis induced by hydroxychloroquine : a case report to confirm a rare association" 74 (74): AB265-, 2016

8 Friedman SJ, "Pustular psoriasis associated with hydroxychloroquine" 16 : 1256-1257, 1987

9 Tselios K, "Psoriasis in systemic lupus erythematosus : a single-center experience" 36 : 879-884, 2017

10 Guerriero C, "Impetigo herpetiformis occurring during N-butyl-scopolammonium bromide therapy in pregnancy : case report" 22 : 141-144, 2008

11 Namazi N, "Impetigo herpetiformis : review of pathogenesis, complication, and treatment" 2018 : 5801280-, 2018

12 Johnston A, "IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis" 140 : 109-120, 2017

13 Sachdeva M, "Hydroxychloroquine effects on psoriasis : a systematic review and a cautionary note for COVID-19 treatment" 83 : 579-586, 2020

14 Hoegler KM, "Generalized pustular psoriasis : a review and update on treatment" 32 : 1645-1651, 2018

15 Said A, "Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells" 193 : 6135-6143, 2014

16 Shindo E, "A case of generalized pustular psoriasis caused by hydroxychloroquine in a patient with systemic lupus erythematosus" 28 : 1017-1020, 2019